Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for BIO-TECHNE Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
William Geist: trading record in brief
William Geist (chief executive) discloses dealings in BIO-TECHNE Corp to SEC (Form 4). Between 1 February 2022 and 15 August 2026, the trades on record add up to 10 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 18 August 2026, reports an option exercise in BIO-TECHNE Corp. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to William Geist
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
6,416 shares0Common StockSEC:0000914190-26-000120:0
1,976 shares@ US$72.400.0013% mcap27.1% of flowCommon StockSEC:0000914190-26-000120:1
9,911 shares0Common StockSEC:0000914190-25-000029:0
2,623 shares0Common StockSEC:0001062993-25-014697:0
803 shares@ US$53.6011.1% of flowCommon StockSEC:0001062993-25-014697:1
3,320 shares0Common StockSEC:0001062993-25-001659:0
3,270 shares@ US$75.3167.8% of flowCommon StockSEC:0001062993-24-018335:1
9,912 shares0Common StockSEC:0001062993-24-018335:0
1,111 shares@ US$68.5421.1% of flowCommon StockSEC:0001062993-24-002021:0
2,490 shares0Common StockSEC:0001437749-22-002402:0
10 of 10 declarations
